IR2

General Information


DRACP ID  DRACP03952

Peptide Name   IR2

Sequence  IRIRPIRIRP

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C58H108N22O11

Absent amino acids  ACDEFGHKLMNQSTVWY

Common amino acids  IR

Mass  145034

Pl  12.98

Basic residues  4

Acidic residues  0

Hydrophobic residues  4

Net charge  4

Boman Index  -4000

Hydrophobicity  -32

Aliphatic Index  156

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31775224

Title  Simplified Head-to-Tail Cyclic Polypeptides as Biomaterial-Associated Antimicrobials With Endotoxin Neutralizing and Anti-Inflammatory Capabilities

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14975

DRACP is developed by Dr.Zheng's team.